Medix Biochemica

Celebrating 40 years of innovation! Medix Biochemica is proud to kick off our 40th anniversary celebration! Since 1985, we've grown from a visionary startup in Finland to a global leader in IVD raw materials – enabling over 1 million diagnostic tests daily. Over the coming months, we'll share insights, stories, and fun facts from our teams around the world. Because at the heart of our success is our people. Join us as we reflect on our journey and look ahead to the future of diagnostics. Read our story and subscribe to stay connected! Read more: https://lnkd.in/d58hr8uY #MedixBiochemica40years #CompanyGrowth #Milestone #Anniversary #WeIVDoThat

Traveling exposes you to new experiences - and new infectious diseases. That's why diagnostic capabilities must be everywhere. Medix Biochemica delivers bulk quantities of critical raw materials with quick turnaround times, enabling faster response to infectious disease threats. Let’s work together to expand testing where it’s needed most. Request a sample today! 👉 https://lnkd.in/dqH-8JES #WeIVDoThat #DiseasePreparedness #Inectious #GlobalHealth

We eagerly anticipate exhibiting and meeting our customers at ESCMID 2025 in Vienna, Austria! Visit us at booth I21 from April 11 - 15 to discuss your infectious disease or molecular diagnostic raw material needs. We look forward to seeing you there! #MedixBiochemica #ESCMID2025

Global health affects us all. Whether at home or traveling, reliable diagnostics are crucial for early detection and outbreak response. Medix Biochemica provides high-quality raw materials for rapid infectious disease tests, supporting global health efforts. Click to request samples! https://lnkd.in/dr9XQjDV Or, contact us to learn how we can help you develop robust diagnostic solutions: https://lnkd.in/dgXdrXWJ #InfectiousDisease #GlobalHealth #Diagnostics #IVD

One size doesn’t fit all in MDx assay development – and it shouldn’t have to. Our custom reagent solutions are designed to match your specific assay needs, whether you’re working with qPCR, NGS, CRISPR, or isothermal amplification. From optimizing sensitivity to streamlining workflows, we help you achieve faster, more reliable results. Let’s collaborate to create a solution that works for you. Set up a free consultation with our team today! (https://lnkd.in/d5gqjCEM #MDx #customservices #MedixBiochemica

Medix Biochemica is a global IVD raw materials supplier with a portfolio of over 5 000 products. In this blog post, we’ll take a closer look at our available products and outline how our broad offering is beneficial to our customers: https://lnkd.in/dPiyDKbS #MedixBiochemica #Services

Speed matters in assay development. Our custom formulations help you reduce complexity, cut costs, and accelerate timelines - so your molecular diagnostic solutions reach the market faster. With deep expertise in qPCR, CRISPR, NGS, RT-qPCR, and isothermal amplification, we’re your partner in innovation, every step of the way. Let’s find the right solution for your project. Schedule a free consultation with our team today! https://lnkd.in/dafyG5f8 #MDxSolutions #CustomAssayDevelopment #MolecularDiagnostics

New: High-Performance NMP22 Antibodies Medix Biochemica’s NMP22 antibodies deliver exceptional sensitivity, scalability, and competitive pricing for bladder cancer diagnostics. Why choose our NMP22 antibodies? ✅ pg/ml sensitivity for high performance ✅ IVD level scalable in vitro manufacturing ✅ ISO 13485 certified for regulatory compliance Recommended Pairs for CLIA: - R12508 (capture) – R12510 (detection) - R12510 (capture) – R12510 (detection) NMP22 supports non-invasive and cost-efficient bladder cancer detection and treatment monitoring. Try some free samples: https://lnkd.in/dZHCYJsh or reach out at info@medixbiochemica.com for more information #BladderCancer #IVD #Biomarkers #Diagnostics #NMP22 #MedixBiochemica

The Medix Biochemica team was proud to participate in the CACLP 2025 exhibition in China this week! It was a fantastic opportunity to connect with industry experts and showcase our latest innovations and growing capabilities. We truly appreciate the insightful discussions and valuable connections made during the event. 📽️ Check out the highlights from CACLP 2025 in our video: https://lnkd.in/dhzZkCTB A big thank you to everyone who visited our booth and attended our seminar - you made this event a memorable one! We look forward to continuing this journey of innovation and excellence together. #CACLP2025 #MedixBiochemica

We’re excited to introduce our NMP22 antibodies, designed to support bladder cancer diagnostics and treatment monitoring. Why NMP22? - A well-established tumor marker for bladder cancer - Found at elevated levels in the urine of affected patients - FDA-approved for detection and monitoring alongside other diagnostic tools - Complements cystoscopy, the current gold standard for diagnosis Advancing Bladder Cancer Testing: - Increasing need for non-invasive, cost-effective, and highly specific diagnostics - Enables IVD manufacturers to develop reliable bladder cancer detection solutions - Supports more accessible and efficient patient care 👉 Request free samples: https://lnkd.in/d4dCrSp2 📧 Contact us: info@medixbiochemica.com #BladderCancer #IVD #Diagnostics #NMP22 #MedixBiochemica